Metabolic benefits of oral polymer-based duodenal exclusion therapy
Glyscend Therapeutics has presented preclinical study results at EASD 2021 evaluating the metabolic effects of once-daily oral therapy in...
top of page
Browse by category
Search
Browse by tag
bottom of page